The PI3K-AKT signaling pathway, which is activated in many cancers, was also investigated, as it emerged as a potential regulatory node, especially since AKT had already been implicated in the regulation of cell survival through the modulation of the BH3-domain-containing protein, BAD (Datta et al., 1997). This evidence concerns the gene AKT1 and cancer.